Association Between Hypoxia-Inducible Factor-2 Alpha (Hif-2 Alpha) Expression And Colorectal Cancer And Its Prognostic Role: A Systematic Analysis
Susu Han,Tao Huang,Wen Li,Shanshan Liu,Wei Yang,Qi Shi,Hongjia Li,Jianlin Ren,Fenggang Hou
DOI: https://doi.org/10.1159/000491806
2018-01-01
Cellular Physiology and Biochemistry
Abstract:Background/Aims: Although some studies showed that HIF-2 alpha expression was correlated with an unfavorable prognosis in colorectal cancer (CRC), the prognostic results remain conflicting in CRC. The present study was performed to evaluate the association between HIF-2 alpha expression and the clinicopathological features of this disease and to examine the potential prognostic role of HIF-2 alpha expression in CRC. Methods: Pooled odds ratios (ORs) or hazard ratios (HRs) were calculated from available publications, The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) datasets. Trial sequential analysis (TSA) was used to estimate the required sample information. Results: HIF-2 alpha protein expression was more frequent in CRC than in normal colonic tissues (OR = 150.49, P < 0.001), higher in male than female CRC patients (OR = 1.47, P = 0.008), and lower in high-grade than low-grade CRC (OR = 0.49, P = 0.029). TSA verified the reliability of the above results. HIF-2 alpha expression was not linked to the prognosis of CRC in overall survival (OS), disease-specific survival (DSS), metastasis-free survival, and relapse-free survival, and no significant correlation was found between HIF-2 alpha alteration and OS or disease-free survival (DFS) of CRC. Expression of both HIF-2 alpha and vascular endothelial growth factor (VEGFA, VEGFB, or VEGFC) was associated with a poor metastasis-free survival of CRC (HR = 6.95, HR = 113.51, and HR = 8.11, respectively). No association was observed between HIF-2 alpha expression and DFS in other cancers, but HIF-2 alpha expression was correlated with a worse DFS of CRC (HR = 1.23, P = 0.037). Moreover, HIF-2 alpha expression was linked to a good survival benefit in some cancers (B-cell lymphoma and lung adenocarcinoma: OS, multiple myeloma: DSS, breast cancer: distant metastasis-free survival, liposarcoma: distant recurrence-free survival) (all HRs < 1, Ps < 0.05). Conclusions: HIF-2 alpha expression may be associated with the carcinogenesis of CRC, which is higher in males than in females, negatively linked to tumor differentiation, and correlated with a worse DFS of CRC. Additional prospective studies are needed. (C) 2018 The Author(s) Published by S. Karger AG, Basel